MedPath

Effectiveness of Telemedicine Care Replacing Standard Care in Gestational Diabetes

Not Applicable
Completed
Conditions
Gestational Diabetes
Interventions
Other: Standard care
Other: Telemedicine care
Registration Number
NCT05521893
Lead Sponsor
University Medical Centre Ljubljana
Brief Summary

This is a a single-centre, parallel, randomized controlled trial in women with gestational diabetes mellitus (GDM). Women are randomized to routine monthly prenatal clinic care (standard care group) or a group sending daily glucose readings via an application installed on a smartphone and monthly individual videoconferences replacing in-person visits (telemedicine group). The overall aim is to compare the effectiveness of the combine synchronous and asynchronous telemedicine care with the standard care in women with GDM.

Detailed Description

In our single-centre, parallel, randomized controlled trial in women with gestational diabetes (GDM) the investigators aim to compare the effectiveness of combined synchonous and asynchronous telemedicine care with the standard care.

In the telemedicine group appointments are performed online via monthly scheduled videoconferences. Women also receive a smartphone with the installed application that enable transfer of the measured capillary glucose concetration at the same time it is performed. The glucose data sent by women are reviewed once per week and after that healthcare professionals contact women if necessary. On the other hand, in the standard care group, visits are scheduled normally on a monthly basis at the diabetes clinic.

Intention-to-treat analysis is going to be performed. The investigators aim to compare glycemic control, gestational weight gain and perinatal data between groups.

Student's t-test or Mann-Whitney U test will be used for normally or non-normally distributed variables. Differences between groups in categorical data will be calcuated by Chi square.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
105
Inclusion Criteria
  • less then 30 weeks of gestation at enrolement
  • GDM diagnosis
  • at least moderate Slovenian language skills
  • willingness to participate
Exclusion Criteria
  • more than 30 weeks of pregnancy
  • overt diabetes or fasting glucose >6.9 mmol/l at diagnosis
  • multiple pregnancy
  • poor Slovene language skills
  • history or bariatric surgery or other surgeries that induce malabsorbtion
  • use of systemic steroids prior to enrolment
  • presence of concomitant disease that could affect glucose control or self-management (e.g. uncontrolled psychiatric disorder)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard care groupStandard care-
Telemedicine groupTelemedicine care-
Primary Outcome Measures
NameTimeMethod
Average postprandial glucose concentration1 month

Average postprandial glucose based on participant's SMBG in the 3rd trimester

Percentage of glucose readings in the target range1 month

average percentage for the 3rd trimester

Compliance with SMBG1 month

is defined as defined as the number of actual glucose measurements performed divided by the number of recommended glucose measurements\*100

Average fasting glucose concentration1 month

Average fasting based on participant's SMBG in the 3rd trimester

The percentage of individuals needing insulin treatmentonce during pregnancy
Secondary Outcome Measures
NameTimeMethod
Incidence of preeclampsiadelivery
gestational weight gainonce during pregnancy

from pre-conception until labour

LGA incidencedelivery
Preterm birthdelivery
Newborn birth weightdelivery
Gestational age at birthdelivery
Incidence of caesarean sectiondelivery

Trial Locations

Locations (1)

University Medical Centre Ljubljana

🇸🇮

Ljubljana, Slovenia

© Copyright 2025. All Rights Reserved by MedPath